Glycogenic Hepatopathy: Resolution with Minimal Glucose Control

Case Reports in Hepatology
Abhimanyu ChandelShaffer Mok

Abstract

We describe a presentation of glycogenic hepatopathy in a poorly controlled type I diabetic patient. As patients with glycogenic hepatopathy often have nonspecific complaints, diagnosis tends to be delayed and laboratory and imaging data are often indistinguishable from nonalcoholic fatty liver disease. Our patient's diagnosis of glycogenic hepatopathy required a liver biopsy, which demonstrated the characteristic pathology. Her symptoms resolved with minimal alteration to her insulin regimen and only slightly improved glucose control.

References

Dec 4, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Seth Sweetser, Robert E Kraichely
Apr 8, 2010·Journal of Gastroenterology and Hepatology·Payal SaxenaRobert McIndoe
Jul 6, 2011·Annals of Saudi Medicine·Khalid S AljabriMohamad A Abaza
Dec 25, 2012·Diabetes Care·Komal Eram ImtiazFiona Karlson
Jun 19, 2013·World Journal of Diabetes·Babu KrishnanJoseph M Pappachan
Jan 25, 2014·Clinical and Molecular Hepatology·Jae Hwang ChaMoon Young Kim
Aug 14, 2015·Case Reports in Gastroenterology·Nishant ParmarKabir Ahmed

❮ Previous
Next ❯

Citations

Mar 13, 2018·World Journal of Hepatology·Jagannath M SherigarSmruti R Mohanty
Jan 9, 2019·Italian Journal of Pediatrics·Fortunato LombardoGiuseppina Salzano

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
insulin replacement therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatrics International : Official Journal of the Japan Pediatric Society
Mamoru SaikusaYasutoshi Koga
JAMA : the Journal of the American Medical Association
Hidekatsu Yanai, Mie Morimoto
JAMA : the Journal of the American Medical Association
Luca Mascitelli, Francesca Pezzetta
Alimentary Pharmacology & Therapeutics
N WlazloC D A Stehouwer
© 2022 Meta ULC. All rights reserved